Speaker Profile
M.D., Senior Vice President, Medical, Castle Biosciences
Biography
Dr. Matthew Goldberg is a board-certified dermatologist and dermatopathologist. Prior to joining Castle, Dr. Goldberg was an Assistant Professor in Dermatology and Pathology at the Icahn School of Medicine at Mount Sinai in New York and retains his affiliation as an Assistant Clinical Professor of Dermatology. Prior to joining the Mount Sinai faculty, he directed Dermatopathology education for the MedStar Georgetown Washington Hospital Center dermatology residency program. Dr. Goldberg has a background in translational melanoma research and received the Dermatology Foundation Dermatopathology Research Career Development Award for research in melanoma epigenetics.
Talk
AI unlocks the clinical utility of spatialomics
Spatialomics provide robust data to interrogate multiple pathways of disease progression simultaneously. Using AI to interpret these pathways can unlock new understanding that has the potential to profoundly improve patient management. This talk will explore how synergies between AI and spatialomics have been validated to predict progression to esophageal cancer in Barretts esophagus patients.
Genomic Profiling Showcase:
Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company focused on improving health through innovative tests that guide patient care. Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2024 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
